Brought to you by 
Valeant pays $A625mm up front and $A75mm in earn-outs for iNova
22 Nov 2011
Executive Summary
In its latest takeover to increase international exposure, serial acquirer Valeant Pharmaceuticals International Inc. has paid $A625mm ($625mm) up front for privately held Australian company iNova Pharmaceuticals Pty. Ltd. (prescription and OTC drugs), which is also entitled to $A75mm in earn-outs tied to pipeline progress, product registrations, and revenues.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Valeant pays $A625mm up front and $A75mm in earn-outs for iNova
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice